A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lipovirtide in HIV-infected Patients
Clinical trial NCT04592315 · COMPLETED
Trial details
- NCT number
- NCT04592315
- Sponsor
- Shanxi Kangbao Biological Product Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-23
- Primary completion
- 2023-05-02
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.